PURE Bioscience, Inc.
PURE - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.1M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $9.10 Million |
|---|---|
| Enterprise Value | $15.13 Million |
| Earnings per Share | $-0.02 |
| Beta | 0.22 |
| Outstanding Shares | 116,456,503 |
Return
| Return on Equity | 38.80% |
|---|---|
| Return on Assets | -208.13% |
| Return on Invested Capital | 65.29% |
Valuation & Multiples
| P/E Ratio | -3.27 |
|---|---|
| PEG | -3.91 |
| Price to Sales | - |
| Price to Book Ratio | -0.07 |
| Enterprise Value to Revenue | 6.53 |
| Enterprise Value to EBIT | -7.29 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.44 |
| Debt to Equity | -1.03 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 29, 2026
EPS
-$0.00
ReportedRevenue
$660,000
ReportedInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About PURE Bioscience, Inc.
11 employees
CEO: Mr. Robert F. Bartlett
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufacture...